President Uhuru Kenyatta led members of the Cabinet and senior government officials to take the AstraZeneca Plc vaccine, which has been ratified by both the World Health Organisation (WHO) and the Africa Centres for Disease Control and Prevention (Africa CDC).

The manner in which the Russian vaccine, whose efficacy reputable global health experts have questioned, was imported by private sector players was itself suspicious.

And so was the public endorsement by Dr Ruto, Mr Abdullahi and another prominent lawyer Donald Kipkorir.

It was apparent that some players were out to make a kill by exploiting public anxiety to make huge profits in a manner that did not raise any suspicions.

While the Russian embassy in Nairobi disowned the imports from Moscow, Kenya has already received a total of 1.1 million AstraZeneca Plc doses from the Covax initiative. This is in addition to another consignment donated by India.

 Free of charge

The vaccine, which is being offered through the ministry of Health and other public facilities, is ideal for ordinary citizens since it is free of charge.

While the available doses are insufficient, they provide a milestone promise for a better tomorrow following an otherwise difficult year in dealing with the ravages of the Covid-19 pandemic, as recently noted by WHO.

This is because the Covax facility is a global initiative working with governments and manufacturers to ensure Covid-19 vaccines are available worldwide to both higher-income and lower-income countries.

The AstraZeneca-Oxford vaccine was manufactured by the Serum Institute of India (SII) and made available to the Covax facility, thanks to an advance purchase agreement between Gavi, the Vaccine Alliance and SII. The doses were procured and transported by UNICEF's Supply Division in Copenhagen.

The consignment already received by Kenya is part of an initial allocation to Kenya of 3.56 million doses.  In addition, Covax is providing 1,025,000 syringes and 10,250 safety boxes to the country via a global stockpile funded and supported by Gavi. Kenya, however, already has enough in-country stocks of syringes and safety boxes for the first phase of vaccinations.

On Saturday, the National Emergency Committee on Coronavirus noted that the AstraZeneca vaccine is being made available to the public not just through the Covax facility but also through the Africa CDC and bilateral platforms as opposed to the Russian vaccine.

The Pharmacy and Poisons Board had allowed private sector imports on the basis that Covid vaccines were being hoarded on the world market and yet the country was keen to ensure they were readily available even outside the priority groups such as security officers, teachers and persons over 58 years of age. 

Counterfeit products 

But as the committee pointed out, unregulated private sector imports not only threatens the gains made in the fight against Covid-19 but also puts the country at international risk should counterfeit products gain entry into the local market.

Since the safety of the Russian vaccine is yet to be subjected to international protocols, the government was, therefore, right to warn that there was a need to urgently close the window for private importation of Covid vaccines in order to ensure transparency and accountability in the programme.

Even worrisome was the obscene profits the importers stood to rake in from selling the vaccine, which was going for an average of Sh8,000 per dose.

The government was right to not only align the country to global Covid 19 procurement mechanisms, but also to protect Kenyans from exploitation.

It is a pity that the ban on importation of Covid-19 vaccines by the private sector has been misinterpreted to be targeting the DP.  The fallacy is that there is a plot to use the Covid vaccines as a political weapon to ensure he does not get a second dose of the Russian vaccine.